IP Library Granted Patent US 9,914,950
Granted Patent B2
US 9,914,950 · App. 14/423,311 · Granted Mar 13, 2018

Homopolymer mediated nucleic acid amplification

Inventors: David W. Lazinski (Franklin, MA); Andrew Camilli (Sharon, MA)
Assignee: Tufts University
C12P19/34C12Q1/6855
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,914,950
App. No.
14/423,311
Granted
Mar 13, 2018
Kind
B2
Abstract

According to some aspects of the invention, provided herein are methods of amplifying nucleic acids using homopolymer-mediated ligation. The methods, in some embodiments, comprise adding a first homopolymer of at least 12 nucleotides to each 3′ end of blunt-ended double-stranded nucleic acid containing a target nucleic acid, thereby producing a partially double-stranded nucleic acid.

Claims (19)

1. A method, comprising

(a) adding a first homopolymer of at least 12 nucleotides to the 3′ end of each nucleic acid strand of a blunt-ended double-stranded nucleic acid containing a target nucleic acid by combining in a single reaction vessel the blunt-ended double-stranded nucleic acid, terminal deoxynucleotidyl transferase (TdT), deoxynucleotide triphosphate (dNTP), and a chain terminator, wherein the ratio of dNTP to chain terminator is at least 11 to 1, thereby producing a partially double-stranded nucleic acid having a homopolymer of at least 12 nucleotides at each 3′ end; and

(b) adding a second homopolymer of at least 4 nucleotides to the 5′ end of each strand of the partially double-stranded nucleic acid, wherein the second homopolymer is attached at its 5′ end to a first oligonucleotide and is shorter than and complementary to the first homopolymer.

2. The method of claim 1 , wherein the second homopolymer of at least 4 nucleotides is added to the 5 ′ end of each nucleic acid strand of the partially double-stranded nucleic acid by combining in a single reaction vessel the partially double-stranded nucleic acid, ligase, and the second homopolymer attached to the first oligonucleotide under conditions that permit ligation.

3. The method of claim 1 , further comprising amplifying the target nucleic acid by polymerase chain reaction using a first primer and a second primer,

wherein the first primer comprises, from 5′ to 3′, (a) a second oligonucleotide that is the same as the first oligonucleotide and (b) a third homopolymer that is the same as the second homopolymer, and

wherein the second primer comprises, from 5′ to 3′, (c) a third oligonucleotide that is different from the first and second oligonucleotides, and (d) a fourth homopolymer that is complementary to the first homopolymer, wherein the fourth homopolymer is longer than the second homopolymer.

4. The method of claim 3 , wherein the fourth homopolymer contains at least 12 nucleotides.

5. The method of claim 1 , wherein the first homopolymer contains deoxycytosine nucleotides or deoxyguanosine nucleotides.

6. The method of claim 1 , wherein the second homopolymer contains deoxycytosine nucleotides or deoxyguanosine nucleotides.

7. The method of claim 3 , wherein the third homopolymer and the fourth homopolymer each contains deoxycytosine nucleotides or deoxyguanosine nucleotides.

8. The method of claim 1 , wherein the first homopolymer is about 15 to about 30 nucleotides in length.

9. The method of claim 1 , wherein the first oligonucleotide contains a restriction endonuclease recognition site, a recombination site, or a promoter for in vitro transcription.

10. The method of claim 1 , wherein the chain terminator is a dideoxynucleotide (ddNTP).

11. The method of claim 10 , wherein the dideoxynucleotide is ddCTP, ddGTP or ddATP.

12. The method of claim 10 , wherein the ratio of dNTP to ddNTP is about 11 to 1 to about 29 to 1.

13. A method, comprising:

(a) adding a first homopolymer of at least 12 nucleotides to the 3′ end of each nucleic acid strand of a blunt-ended double-stranded nucleic acid containing, from 5′ to 3′, a known target region contiguous with an unknown target region, by combining in a single reaction vessel the blunt-ended double-stranded nucleic acid, terminal deoxynucleotidyl transferase (TdT), deoxynucleotide triphosphate (dNTP), and a chain terminator, wherein the ratio of dNTP to chain terminator is at least 11 to 1, thereby producing a first partially double-stranded nucleic acid having a homopolymer of at least 12 nucleotides at each 3′ end; and

(b) amplifying the known and unknown target regions by polymerase chain reaction using a first primer and a second primer, wherein the first primer contains, from 5′ to 3′, a first oligonucleotide and a second oligonucleotide that is the same as at least a portion of the known target region; and the second primer contains, from 5′ to 3′, a second oligonucleotide different from the first oligonucleotide, and a second homopolymer complementary to the first homopolymer.

Assignments (4)
CONFIRMATORY LICENSE Recorded Jan 4, 2017
From: TUFTS UNIVERSITY BOSTON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 041239/0668 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 14, 2015
From: LAZINSKI, DAVID W.; CAMILLI, ANDREW; HOWARD HUGHES MEDICAL INSTITUTE
To: TUFTS UNIVERSITY
Reel/Frame 035640/0296 →
CONFIRMATION OF ASSIGNMENT Recorded May 14, 2015
From: CAMILLI, ANDREW
To: HOWARD HUGHES MEDICAL INSTITUTE
Reel/Frame 035664/0634 →
APPOINTMENT OF INVESTIGATOR AS AGENT Recorded May 14, 2015
From: HOWARD HUGHES MEDICAL INSTITUTE
To: CAMILLI, ANDREW
Reel/Frame 035664/0637 →
Continuity (2)
Provisional Application 61692502 · Aug 23, 2012
Related Publication 20150203887A1 · Jul 23, 2015